Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative.

Tzu Chi University

Status: Unknown

Conditions: Lung Cancer Non Small Cell

Treatments: Behavioral: Walk; Behavioral: Baduanjin plus walk; Other: usual care; Behavioral: Baduanjin

Study type: Interventional

Funder types: Other

Identifiers

NCT04669730

TCU-CHHuang-BaduanjinLungCa

Details and patient eligibility

About

Lung cancer (LC) is the leading cause of cancer-related death and is the most frequent cancer in both sexes.Respectable lung tumor with abnormal lung function, usually because of tobacco use, have chronic obstructive pulmonary disease (COPD), coronary artery disease, and/or old age as underlying comorbidities. Until recent, most exercise prescribed using aerobic exercise programs. Baduanjin is a type of movement-based mind-body intervention. It is a form of traditional practice designed to promote physical and psychological health, manage symptoms, and relieve stress during illness. The impacts of a Baduanjin exercise-based cardiopulmonary rehabilitation program for patients recovering from respectable lung tumor on Meridian Energy Analysis Device (MEAD100, Med- Pex Enterprises, Taichung, Taiwan), lung function and heart rate variability has yet to be assessed. This trial evaluates whether the Baduanjin exercise would provide effective lung function, meridian energy and HRV in patients following lung operative.

Enrollment: 120 estimated patients

Sex: All

Ages: 20 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of primary NSCLC based on preoperative pathologic examination
• Had no surgical contraindication to and were willing to undergo video-assisted thoracic surgery or traditional thoracotomy (open) lobectomy
• Agreed to receive exercise performed.

Exclusion criteria

• SpO2 <90% during the 6-min walking test
• With an absence of NSCLC, as confirmed by postoperative pathologic examination or with sub-lobar resection or pneumonectomy

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Double Blind

---

120 participants in 4 patient groups, including a placebo group

Arm A: usual care

Placebo Comparator group

Description:

Routine usual care

Treatment:

Other: usual care

Arm B: walk

Active Comparator group

Description:

Walk 30mins per day, 5 days per week.

Treatment:

Behavioral: Walk

Arm C: Baduanjin

Active Comparator group

Description:

Baduanjin 12 mins per day, 5 days per week.

Treatment:

Behavioral: Baduanjin

Arm D: Baduanjin plus walk

Experimental group

Description:

Walk 30mins then Baduanjin 12 mins per day, 5 days per week.

Treatment:

Behavioral: Baduanjin plus walk